NeuroMetrix' Quell Device Makes Second Appearance at the American Podiatric Medical Association Annual Scientific Meeting

100% Drug Free, FDA Cleared Wearable for Widespread Relief from Chronic Pain

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell^® Wearable Pain Relief Technology^™ will be featured for the second year in a row at the American Podiatric Medical Association's Annual Scientific Meeting to be held July 14-17 in Philadelphia.

"We are excited to share the latest clinical science behind Quell, including a study published last month in the Journal of Pain Research that documented the effectiveness of Quell in treating lower back and extremity pain," says Shai Gozani, M.D., Ph.D., CEO and President of NeuroMetrix. "With 77% of American adults suffering from foot pain, podiatrists play a very important role in helping to treat pain."

About Quell

Quell utilizes NeuroMetrix's patented neurostimulation technology to provide widespread relief from chronic pain. The advanced wearable device is lightweight and can be worn during the day while active and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. The optional "Quell Relief" smartphone app allows users to track and personalize their pain therapy. Quell was recently awarded the Innovation Award at SXSW for Best Wearable Technology. It is available for purchase at QuellRelief.com, selected retailers and healthcare professionals.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160712006183/en/

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media